JPM

308.64

-1.06%↓

BAC

51.99

-0.95%↓

188.1

-0.31%↓

928.02

-0.36%↓

WFC

79.46

-1.27%↓

JPM

308.64

-1.06%↓

BAC

51.99

-0.95%↓

188.1

-0.31%↓

928.02

-0.36%↓

WFC

79.46

-1.27%↓

JPM

308.64

-1.06%↓

BAC

51.99

-0.95%↓

188.1

-0.31%↓

928.02

-0.36%↓

WFC

79.46

-1.27%↓

JPM

308.64

-1.06%↓

BAC

51.99

-0.95%↓

188.1

-0.31%↓

928.02

-0.36%↓

WFC

79.46

-1.27%↓

JPM

308.64

-1.06%↓

BAC

51.99

-0.95%↓

188.1

-0.31%↓

928.02

-0.36%↓

WFC

79.46

-1.27%↓

Kodu・Aktsiate loetelu・Goldman Sachs BDC Inc

G
Goldman Sachs BDC Inc

Suletud

9.48 0.21

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

9.48

Max

9.54

Põhinäitajad
By Trading Economics
Sissetulek	-985K 24M
Müük	27M 83M
P/E Sektori keskmine	9.485 39.62
Dividenditootlus	13.07
Kasumimarginaal	28.503
EBITDA	73M 98M

Soovitused
By TipRanks
Soovitused	Müü
12 kuu keskmine prognoos	-5.06% downside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	13.07% 4.52%
Järgmine tulemuste avaldamine	7. mai 2026
Järgmine dividendimakse kuupäev	28. apr 2026
Järgmine aktsia dividendi kuupäev (ex-date)	29. juuni 2026

Turustatistika
By TradingEconomics
Turukapital	65M 1.1B
Eelmine avamishind	9.27
Eelmine sulgemishind	9.48

Tehniline skoor

By Trading Central

Kindlus

Weak Bearish Evidence

10.4161 / 10.7001 Toetus ja vastupanu

Goldman Sachs BDC Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. apr 2026, 19:19 UTC

Omandamised, ülevõtmised, äriostud

Intertek Group Rejects EQT's Revised Offer

24. apr 2026, 23:37 UTC

Omandamised, ülevõtmised, äriostud

Scoring the Cook Era -- Barrons.com

24. apr 2026, 20:51 UTC

Omandamised, ülevõtmised, äriostud

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. apr 2026, 20:50 UTC

Market Talk

Uudisväärsed sündmused

Financial Services Roundup: Market Talk

24. apr 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

24. apr 2026, 20:39 UTC

Omandamised, ülevõtmised, äriostud

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. apr 2026, 20:09 UTC

Tulu

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24. apr 2026, 19:48 UTC

Market Talk

Uudisväärsed sündmused

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24. apr 2026, 19:25 UTC

Omandamised, ülevõtmised, äriostud

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. apr 2026, 19:25 UTC

Omandamised, ülevõtmised, äriostud

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24. apr 2026, 19:22 UTC

Tulu

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24. apr 2026, 19:06 UTC

Tulu

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24. apr 2026, 19:05 UTC

Market Talk

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24. apr 2026, 18:30 UTC

Omandamised, ülevõtmised, äriostud

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24. apr 2026, 18:28 UTC

Omandamised, ülevõtmised, äriostud

Intertek Rejects Revised EQT Offer

24. apr 2026, 18:12 UTC

Market Talk

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24. apr 2026, 18:06 UTC

Market Talk

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24. apr 2026, 17:42 UTC

Tulu

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24. apr 2026, 17:28 UTC

Tulu

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

24. apr 2026, 17:28 UTC

Market Talk

Crypto Fear and Greed Index Slides Back to Neutral -- Market Talk

24. apr 2026, 17:12 UTC

Market Talk

Global Equities Roundup: Market Talk

24. apr 2026, 17:11 UTC

Market Talk

Apple Seen Gaining Market Share Despite Memory Crunch -- Market Talk

24. apr 2026, 17:09 UTC

Market Talk

Tulu

Intel Seen With Stronger Long-Term Earnings Power -- Market Talk

24. apr 2026, 17:09 UTC

Omandamised, ülevõtmised, äriostud

Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. apr 2026, 17:06 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Correction to Advanced Micro Devices Stock Gets Upgraded to Buy. Why It's the Big Winner of Intel Earnings. -- Barrons.com

24. apr 2026, 16:51 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Two Big Loan Defaults Add to Pain in Private-Credit Funds -- WSJ

24. apr 2026, 16:20 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

24. apr 2026, 16:20 UTC

Market Talk

Uudisväärsed sündmused

Financial Services Roundup: Market Talk

24. apr 2026, 16:20 UTC

Market Talk

Tulu

Auto & Transport Roundup: Market Talk

24. apr 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Goldman Sachs BDC Inc Prognoos

Hinnasiht

By TipRanks

-5.06% langus

12 kuu keskmine prognoos

Keskmine 9 USD -5.06%

Kõrge 10 USD

Madal 8 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Goldman Sachs BDC Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Müü

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Goldman Sachs BDC Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

10.4161 / 10.7001Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Goldman Sachs BDC Inc

Goldman Sachs BDC, Inc. is a business development company specializing in middle market and mezzanine investment in private companies. It seeks to make capital appreciation through direct originations of secured debt, senior secured debt, junior secured debt, including first lien, first lien/last-out unitranche and second lien debt, unsecured debt, including mezzanine debt and, to a lesser extent, investments in equities. The fund primarily invests in United States. It seeks to invest between $10 million and $75 million in companies with EBITDA between $5 million and $75 million annually.